CIDARA THERAPEUTICS INC (CDTX)

US1717571079 - Common Stock

12.79  +0.16 (+1.27%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
56.54M64.29M49.57M12.07M20.92M
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
87.83M94.01M91.83M83.92M62.64M
Research and Development
73.25M75.52M73.09M68.02M46.40M
Selling, General, and Administrative Expenses
14.60M18.49M18.74M15.90M16.24M
Operating Income
-31.68M-29.72M-42.26M-71.85M-41.72M
Interest Income/Expense
1.62M190.00K-210.00K-260.00K630.00K
Other Income/Expense
N/AN/AN/AN/A0.00
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-30.05M-29.53M-42.47M-72.11M-41.09M
Income Tax
N/A270.00KN/AN/A0.00
Net Income
-31.38M-29.80M-42.47M-74.87M-41.09M
EBITDA
-31.57M-29.58M-42.07M-71.56M-41.39M
 
Per Share Data
EPS Diluted Total Ops
-0.39-0.43-0.81-1.80-1.41
Non GAAP EPS
-0.39-0.48-0.84-1.81-1.43
 
Statistics
Profit Margin
-55.50%-46.35%-85.68%-620.30%-196.41%
Operating Profit Margin
-56.03%-46.23%-85.25%-595.28%-199.43%

All data in USD

Charts